Lupin season 4 will be releasing on Netflix even though the production for the same is yet to commence, according to a report.

Lupin Ltd appointed Abdelaziz Toumi as CEO of its new subsidiary, Lupin Manufacturing Solutions (LMS). Toumi, with over 20 years in biotech...

Gulmarg, a popular tourist destination in Jammu and Kashmir, experienced its first snowfall of the season on Friday. The Machil sector of K...

While fans eagerly await news of Lupin Season 4, series creator George Kay provides a glimpse into the potential future of the show followi...

Netflix's most watched movies and series in the English and non-English categories have been unveiled.

"Lupin," which debuted on Netflix in 2021, has garnered a dedicated following, thanks to its gripping storyline and outstanding performance...

Get ready for a thrilling October on Netflix with an array of exciting original movies and series. From action-packed thrillers to captivat...

Lupin, Apollo Tyres, Westlife, Raymond and Nazara are set to release their Q4 results on Tuesday. Lupin is expected to report a profit of R...

Netflix Germany posted on Twitter that they had intended to reveal the release date for Lupine Part 3, but it seems someone else had other ...

The movie is Samuel's follow-up to his Netflix westerner 'The Harder They Fall'.

The Mumbai-based drugmaker had reported a net profit of Rs 438.3 crore in the October-December quarter of the previous fiscal.

The Spanish series - its original title, La Casa de Pape, literally translates as 'The House of Paper - is about a band of robbers, led by ...

The company had posted a net loss of Rs 835 crore for the corresponding period of the previous fiscal, Lupin said in a late night filing to...

Buy Lupin at a price target of Rs 985.

Last week, Lupin, Cadila Healthcare and Alembic Pharma received clearances from the US regulator for their key facilities.

Mumbaibased pharma company Lupin has posted better-than-expected numbers after reporting dismal figures for four successive quarters.

Pharma major Lupin has acquired the global rights for an intra-nasal steroid (INS) product, AllerNaze. The Mumbai-based company has acquire...